CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW


TWO TECHNOLOGIES

ONE OBJECTIVE


To convert cancer and other degenerative diseases into non-lethal manageable conditions


Dr Graham Kelly, Executive Chairman

CLICK HERE TO READ OUR INVESTOR PRESENTATION

CLICK HERE TO READ OUR INVESTOR PRESENTATION

CLICK HERE TO READ OUR INFORMATION MEMORANDUM

CLICK HERE TO READ OUR INFORMATION MEMORANDUM

 

CAPITAL RAISING RESOURCES

All the Latest News >         STOP PRESS

You Can Now View the Recorded Webinar  HERE

CEO Interview with ShareCafe  HERE

Capital Raise Option Clarification HERE

CAPITAL RAISING INFORMATION


Placement Via Your Broker

Step 1    Complete ASX BookBuild Client Agreement & send to your broker.  
Step 2   Your broker can then submit on your behalf using the ASX ticker NRTXBB


Placement Direct With Novogen

Step 1    Investors must be classified as Sophisticated Investors and have completed a certificate by a qualified accountant   
Step 2    Complete Sophisticated Investor Application Form and deposit funds into escrow account
Step 3    Send completed application form to cristyn.humphreys@novogen.com before closing date


More information about ASX BookBuild
Information on the ASX BookBuild Facility can be found on the ASX website on the links below.

CONTACT DETAILS

Novogen Enquiries
Dr Graham Kelly
CEO Novogen Group

Graham.Kelly@novogen.com
+(61 2) 9472 4100

Investor Direct Placement Enquiries
Cristyn Humphreys
Operations Manager Novogen Group

Cristyn.Humphreys@Novogen.com
+ 61 2 9472 4111
+ 61 499 088 482

Advisor to the Offer
Matt Christensen
Hill Capital

matthewc@hillcapital.com.au
+(61 2) 9416 5399

Media Enquiries

Cristyn Humphreys
Operations Manager Novogen Group

Cristyn.Humphreys@Novogen.com
+ 61 2 9472 4111
+ 61 499 088 482